Big Move For Mesoblast Limited
Wed, Dec 15, 2021 at 05:30 PM
Mesoblast Limited (MESO:NASDAQ) rocketted at $4.97, representing a gain of 19.2%. On Tue, Dec 14, 2021, MESO:NASDAQ touched a New 2-Week Low of $4.17. The stock got featured on our News Catalysts scanner on Mon, Dec 13, 2021 at 08:14 PM in the 'AGREEMENT' category. From Tue, Nov 30, 2021, the stock recorded 20.00% Up Days and 18.18% Green Days
About Mesoblast Limited (MESO:NASDAQ)
Mesoblast Ltd is engaged in the development of biologic products for the broad field of regenerative medicine. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells.
Top 10 Gainers:
- THRX (THRX:NASDAQ), 34.12%
- Cabot Microelectronics Corporation (CCMP:NASDAQ), 33.93%
- BFRI (BFRI:NASDAQ), 26.36%
- American Virtual Cloud Technologies, Inc. (AVCT:NASDAQ), 25.41%
- Regional Health Properties, Inc. (RHE:NYSEMKT), 23.84%
- GMTX (GMTX:NASDAQ), 23.05%
- CNEY (CNEY:NASDAQ), 22.36%
- Mesoblast Limited (MESO:NASDAQ), 19.18%
- BSN (BSN:NYSE), 19.06%
- MTCR (MTCR:NASDAQ), 18.7%